L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats

NeuroReport

Volumn 25, Issue 1, 2014, Pages 7-11

  Yue, Kai ^a   Ma, Baomiao ^a   Chen, Lin ^a   Tian, Xiang ^a   Ru, Qin ^a   Gan, Yongping ^b   Wang, Daisong ^b   Jin, Guozhang ^a,c   Li, Chaoying ^a  

^a JIANGHAN UNIVERSITY   (China)

^b Hubei Public Security Bureau   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

dopamine receptor; heroin; L stepholidine; relapse; self administration

Indexed keywords

DIAMORPHINE; STEPHOLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELF ADMINISTRATION; HEROIN DEPENDENCE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; BEHAVIOR, ANIMAL; BERBERINE; CONDITIONING, OPERANT; CUES; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXTINCTION, PSYCHOLOGICAL; HEROIN; MALE; MOTOR ACTIVITY; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 84889881055     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000012     Document Type: Article

References (29)

1. Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron 1998; 21:467-476
2. Pierce RC, Kumaresan V. The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abusëNeurosci Biobehav Rev 2006; 30:215-238
3. Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: A review. Pharmacol Rev 2002; 54:1-42
4. Woolverton WL, Ranaldi R. Comparison of the reinforcing efficacy of two dopamine D2-like receptor agonists in rhesus monkeys using a progressive-ratio schedule of reinforcement. Pharmacol Biochem Behav 2002; 72:803-809
5. Haile CN, Kosten TA, Kosten TR. Pharmacogenetic treatments for drug addiction: Alcohol and opiates. Am J Drug Alcohol Abuse 2008; 34:355-381
6. Pulvirenti L, Koob GF. Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 1994; 15:374-379
7. Vetulani J. Drug addiction. Part III. Pharmacotherapy of addiction. Pol J Pharmacol 2001; 53:415-434
8. Sabioni P, D'Almeida V, Andersen ML, Andreatini R, Galduroz JC. SKF 38393 reverses cocaine-conditioned place preference in mice. Neurosci Lett 2012; 513:214-218
9. Zhang D, Wang X, Xiang X, Chen H, Zhang J, Su Q, Hao W. The dopamine D(2) partial agonist and antagonist terguride decreases heroin selfadministration on fixed- and progressive-ratio schedules. Pharmacol Biochem Behav 2010; 97:222-226
10. Jin GZ, Zhu ZT, Fu Y. (-)-Stepholidine: A potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci 2002; 23:4-7
11. Natesan S, Reckless G, Barlow K, Odontiadis J, Nobrega J, Baker G, et al. The antipsychotic potential of L-stepholidine - a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Psychopharmacology (Berl) 2008; 199:275-289
12. Wang W, Zhou Y, Sun J, Pan L, Kang L, Dai Z, et al. The effect of L-stepholidine, a novel extract of Chinese herb, on the acquisition, expression, maintenance, and re-acquisition of morphine conditioned place preference in rats. Neuropharmacology 2007; 52:355-361
13. Liu ZH, Jin WQ, Zhang HP, Chen XJ, Jin GZ. Suppression of morphineinduced conditioned place preference by L-12-chloroscoulerine, a novel dopamine receptor ligand. Pharmacol Biochem Behav 2003; 75:289-294
14. Yue K, Ma B, Ru Q, Chen L, Gan Y, Wang D, et al. The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats. Pharmacol Biochem Behav 2012; 102:1-5
15. Liu YL, Yan LD, Zhou PL, Wu CF, Gong ZH. Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats. Eur J Pharmacol 2009; 602:321-327
16. Gao M, Chu HY, Jin GZ, Zhang ZJ, Wu J, Zhen XC. L-Stepholidine-induced excitation of dopamine neurons in rat ventral tegmental area is associated with its 5-HT(1A) receptor partial agonistic activity. Synapse 2011; 65: 379-387
17. Zhang F. SuperState: A computer program for the control of operant behavioral experimentation. J Neurosci Methods 2006; 155:194-201
18. Evans SM, Foltin RW. The effects of D-amphetamine on the reinforcing effects of food and fluid using a novel procedure combining selfadministration and location preference. Behav Pharmacol 1997; 8: 429-441
19. Aguilar MA, Rodríguez-Arias M, Miñarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 2009; 59:253-277
20. Bardo MT. Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 1998; 12:37-67
21. Lynch WJ, Nicholson KL, Dance ME, Morgan RW, Foley PL. Animal models of substance abuse and addiction: Implications for science, animal welfare, and society. Comp Med 2010; 60:177-188
22. Hnasko TS, Sotak BN, Palmiter RD. Morphine reward in dopaminedeficient mice. Nature 2005; 438:854-857
23. Franken IH, Booij J, van den Brink W. The role of dopamine in human addiction: From reward to motivated attention. Eur J Pharmacol 2005; 526:199-206
24. Mello NK, Negus SS. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 1996; 14:375-424
25. Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben-Shahar O. Control of cocaine-seeking behavior by drug-associated stimuli in rats: Effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci USA 2000; 97:4321-4326
26. See RE. Dopamine D1 receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse. Int J Neuropsychopharmacol 2009; 12:431-436
27. Tobin S, Newman AH, Quinn T, Shalev U. A role for dopamine D1-like receptors in acute food deprivation-induced reinstatement of heroin seeking in rats. Int J Neuropsychopharmacol 2009; 12:217-226
28. Mo J, Guo Y, Yang YS, Shen JS, Jin GZ, Zhen X. Recent developments in studies of L-stepholidine and its analogs: Chemistry, pharmacology and clinical implications. Curr Med Chem 2007; 14:2996-3002
29. Mo J, Zhang H, Yu LP, Sun PH, Jin GZ, Zhen X. L-Stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiol Aging 2010; 31:926-936